Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Growing public interest in earlier access to experimental drugs for life-threatening conditions such as cancer has stimulated proposals for legislation that would promote or even create rights to access. But if the importance of properly conducted clinical trials is not valued appropriately, such actions could be detrimental to drug development and patient care.